Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Flohr

Showing results (111-120 of 191) with videos related to

Pageof 20
Sort By:
JAMA Dermatology|August 18, 2021
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical TrialLawrence F Eichenfield, Carsten Flohr, Robert Sidbury, et al.
JMIR Dermatology|August 26, 2023
Development of a Website for a Living Network Meta-analysis of Atopic Dermatitis Treatments Using a User-Centered Design: Multimethod StudyKaren P L Lau, Payal Agarwal, Laura Parente, et al.
The British Journal of Dermatology|June 27, 2025
Atopic dermatitis epidemiological research methodology: a global scoping reviewChih-Ya Chang, Kaitlyn Chan, Hsuan-Chi Chen, et al.
JAMA Dermatology|March 2, 2017
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Contact Dermatitis|March 5, 2025
The Prevalence and Severity of Hand Eczema Among Adults in Tasiilaq, East GreenlandMorten Bahrt Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)Eric L Simpson, Carsten Flohr, Lawrence F Eichenfield, et al.
International Journal of Circumpolar Health|October 3, 2024
Skin diseases among adults in Tasiilaq, East GreenlandMorten B Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 14, 2023
Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP)Hsi Yen, Hsuan Yen, Chun-Hsien Huang, et al.
Allergy|July 20, 2023
Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitisShona Cameron, Ali Donnelly, Conor Broderick, et al.
Pageof 20

Showing results (111-120 of 191) with videos related to

Sort By:
Pageof 20
JAMA Dermatology|August 18, 2021
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical TrialLawrence F Eichenfield, Carsten Flohr, Robert Sidbury, et al.
JMIR Dermatology|August 26, 2023
Development of a Website for a Living Network Meta-analysis of Atopic Dermatitis Treatments Using a User-Centered Design: Multimethod StudyKaren P L Lau, Payal Agarwal, Laura Parente, et al.
The British Journal of Dermatology|June 27, 2025
Atopic dermatitis epidemiological research methodology: a global scoping reviewChih-Ya Chang, Kaitlyn Chan, Hsuan-Chi Chen, et al.
JAMA Dermatology|March 2, 2017
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Contact Dermatitis|March 5, 2025
The Prevalence and Severity of Hand Eczema Among Adults in Tasiilaq, East GreenlandMorten Bahrt Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)Eric L Simpson, Carsten Flohr, Lawrence F Eichenfield, et al.
International Journal of Circumpolar Health|October 3, 2024
Skin diseases among adults in Tasiilaq, East GreenlandMorten B Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 14, 2023
Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP)Hsi Yen, Hsuan Yen, Chun-Hsien Huang, et al.
Allergy|July 20, 2023
Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitisShona Cameron, Ali Donnelly, Conor Broderick, et al.
Pageof 20